These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 26126937)

  • 1. FGF23-FGF Receptor/Klotho Pathway as a New Drug Target for Disorders of Bone and Mineral Metabolism.
    Fukumoto S
    Calcif Tissue Int; 2016 Apr; 98(4):334-40. PubMed ID: 26126937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone-kidney axis in systemic phosphate turnover.
    Razzaque MS
    Arch Biochem Biophys; 2014 Nov; 561():154-8. PubMed ID: 24997362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FGF23 and Bone and Mineral Metabolism.
    Fukumoto S
    Handb Exp Pharmacol; 2020; 262():281-308. PubMed ID: 31792685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bone and Calcium Research Update 2015. Novel treatment for FGF23-related hypophosphatemic diseases].
    Fukumoto S
    Clin Calcium; 2015 Jan; 25(1):37-44. PubMed ID: 25530521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiological regulation and disorders of phosphate metabolism--pivotal role of fibroblast growth factor 23.
    Fukumoto S
    Intern Med; 2008; 47(5):337-43. PubMed ID: 18310961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological inhibition of fibroblast growth factor (FGF) receptor signaling ameliorates FGF23-mediated hypophosphatemic rickets.
    Wöhrle S; Henninger C; Bonny O; Thuery A; Beluch N; Hynes NE; Guagnano V; Sellers WR; Hofmann F; Kneissel M; Graus Porta D
    J Bone Miner Res; 2013 Apr; 28(4):899-911. PubMed ID: 23129509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical aspect of recent progress in phosphate metabolism. The pathophysiology of diseases caused by aberrant actions of FGF23].
    Shimizu Y; Fukumoto S
    Clin Calcium; 2009 Jun; 19(6):802-7. PubMed ID: 19483274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Updates on rickets and osteomalacia: anti-FGF23 antibody, a new therapeutic approach for hypophosphatemic rickets/osteomalacia].
    Shimada T
    Clin Calcium; 2013 Oct; 23(10):1469-75. PubMed ID: 24076645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in understanding of phosphate homeostasis and related disorders.
    Michigami T
    Endocr J; 2022 Aug; 69(8):881-896. PubMed ID: 35831119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. X-Linked Hypophosphatemia and FGF23-Related Hypophosphatemic Diseases: Prospect for New Treatment.
    Kinoshita Y; Fukumoto S
    Endocr Rev; 2018 Jun; 39(3):274-291. PubMed ID: 29381780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FGF23-related hypophosphatemic rickets/osteomalacia: diagnosis and new treatment.
    Fukumoto S
    J Mol Endocrinol; 2021 Feb; 66(2):R57-R65. PubMed ID: 33295878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Disorders of phosphate metabolism].
    Fukumoto S
    Rinsho Byori; 2010 Mar; 58(3):225-31. PubMed ID: 20408440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hormones and osteoporosis update. FGF23/Klotho and bone metabolism].
    Fukumoto S
    Clin Calcium; 2009 Jul; 19(7):945-50. PubMed ID: 19567989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rickets/Osteomalacia. FGF23-related hypophosphatemic rickets/osteomalacia.].
    Fukumoto S
    Clin Calcium; 2018; 28(10):1313-1317. PubMed ID: 30269112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fibroblast growth factor (FGF) 23 works as a phosphate-regulating hormone and is involved in the pathogenesis of several disorders of phosphate metabolism].
    Fukumoto S
    Rinsho Byori; 2007 Jun; 55(6):555-9. PubMed ID: 17657990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear isoforms of fibroblast growth factor 2 are novel inducers of hypophosphatemia via modulation of FGF23 and KLOTHO.
    Xiao L; Naganawa T; Lorenzo J; Carpenter TO; Coffin JD; Hurley MM
    J Biol Chem; 2010 Jan; 285(4):2834-46. PubMed ID: 19933269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bone and joint diseases in children. Phosphaturic hormone, FGF23, and bone metabolism].
    Ozono K
    Clin Calcium; 2010 Jun; 20(6):896-903. PubMed ID: 20513948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypophosphatemic rickets: lessons from disrupted FGF23 control of phosphorus homeostasis.
    Goldsweig BK; Carpenter TO
    Curr Osteoporos Rep; 2015 Apr; 13(2):88-97. PubMed ID: 25620749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble Klotho causes hypomineralization in Klotho-deficient mice.
    Minamizaki T; Konishi Y; Sakurai K; Yoshioka H; Aubin JE; Kozai K; Yoshiko Y
    J Endocrinol; 2018 Jun; 237(3):285-300. PubMed ID: 29632215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Updates on rickets and osteomalacia: various roles of Klotho and FGF23 in vivo ].
    Imura A
    Clin Calcium; 2013 Oct; 23(10):1476-82. PubMed ID: 24076646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.